Mulmit

IMPACT BIOMEDICAL INC.IMPACT BIOMEDICAL INC.

IBO NYSE

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-3132,000-4,282,000-11,838,000-0.38
2022-12-3150,000-3,404,000-7,255,000-0.1

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-03-27Macko Todd DChief Financial Officer43,400
2026-03-25Macko Todd DChief Financial Officer1,600
2026-03-23Grady Jason50,000
2025-05-27DSS, INC.45,400
2025-05-27DSS, INC.45,400
2025-05-22DSS, INC.115,600
2025-05-22DSS, INC.115,600
2025-04-04DSS, INC.890,800
2025-04-03Chan Heng Fai Ambrose351,555
2025-03-27DSS, INC.47,681
2025-03-26DSS, INC.48,281
2025-03-26DSS, INC.9,858

8-K events

FiledItems
2026-09-17Regulation FD disclosure · Financial statements and exhibits
2026-09-15Regulation FD disclosure · Financial statements and exhibits
2026-03-04Entry into a material agreement · Financial statements and exhibits
2025-11-06Submission of matters to a vote
2025-10-27Other events
2025-07-28Entry into a material agreement · Financial statements and exhibits
2025-06-23Entry into a material agreement · Regulation FD disclosure · Financial statements and exhibits
2025-04-03Entry into a material agreement
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.